Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220525 | SCV001392520 | pathogenic | Hereditary spastic paraplegia 7 | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg247*) in the SPG7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG7 are known to be pathogenic (PMID: 21623769, 22964162). This variant is present in population databases (rs779055639, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 21623769). ClinVar contains an entry for this variant (Variation ID: 949128). For these reasons, this variant has been classified as Pathogenic. |
Genetic Services Laboratory, |
RCV001819912 | SCV002064530 | pathogenic | not provided | 2019-01-08 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the SPG7 gene demonstrated a sequence change, c.739C>T, which results in the creation of a premature stop codon at amino acid position 247, p.Arg247*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated SPG7 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a low population frequency of 0.0022% (rs779055639). This sequence change has previously been described in a patient with spastic paraplegia in the compound heterozygous state with a missense pathogenic variant (Schlipf et al., 2011). |
Fulgent Genetics, |
RCV001220525 | SCV002807925 | pathogenic | Hereditary spastic paraplegia 7 | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001819912 | SCV004168302 | pathogenic | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 30683863, 21623769, 34758253) |
PROSPAX |
RCV001220525 | SCV005061886 | pathogenic | Hereditary spastic paraplegia 7 | 2022-01-01 | criteria provided, single submitter | research | |
Genomics England Pilot Project, |
RCV001220525 | SCV001760387 | pathogenic | Hereditary spastic paraplegia 7 | no assertion criteria provided | clinical testing |